XML 52 R38.htm IDEA: XBRL DOCUMENT
v3.26.1

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Option Activity | The following table summarizes option activity during the years ended December 31, 2025 and 2024: Schedule of Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Fair Value |  |  | Weighted Average Remaining Contractual Life (Years) |
Outstanding at December 31, 2023 |  |  | 34,695 |  |  | $ | 65.70 |  |  | $ | 41.10 |  |  |  | 4.89 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Forfeited/Cancelled |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Outstanding at December 31, 2024 |  |  | 34,695 |  |  | $ | 65.70 |  |  | $ | 41.10 |  |  |  | 3.88 |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Expired |  |  | (2,334 | ) |  | $ | 38.77 |  |  | $ | 22.80 |  |  |  |  |
Forfeited/Cancelled |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Exercised |  |  | (758 | ) |  |  | 16.50 |  |  |  | 14.65 |  |  |  |  |
Outstanding at December 31, 2025 |  |  | 31,603 |  |  | $ | 68.91 |  |  | $ | 43.05 |  |  |  | 3.14 |
Exercisable at December 31, 2025 |  |  | 31,603 |  |  | $ | 68.91 |  |  | $ | 43.05 |  |  |  | 3.14 |
Schedule of Outstanding Restricted Stock Units and Related Activity | The grant date fair value of RSUs granted is determined using the closing market price of the Company’s common stock on the grant date with the associated compensation expense amortized over the vesting period of the awards. The following table sets forth the outstanding RSUs and related activity for the years ended December 31, 2025 and 2024: Schedule of Outstanding Restricted Stock Units and Related Activity
|  | Number of RSUs |  |  | Weighted Average Grant Date Fair Value |
Unvested at December 31, 2023 |  |  | 97,517 |  |  | $ | 119.70 |
Granted |  |  | 51,834 |  |  |  | 33.30 |
Vested |  |  | (49,306 | ) |  |  | 129.00 |
Forfeited/Cancelled |  |  | (8,634 | ) |  |  | 121.20 |
Unvested at December 31, 2024 |  |  | 91,411 |  |  | $ | 75.00 |
Granted |  |  | 86,847 |  |  |  | 7.58 |
Vested |  |  | (58,092 | ) |  |  | 48.50 |
Forfeited/Cancelled |  |  | (6,141 | ) |  |  | 120.61 |
Unvested at December 31, 2025 |  |  | 114,025 |  |  | $ | 34.51 |
Schedule of Warrant Activity | The following table summarizes warrant activity during the years ended December 31, 2025 and 2024: Schedule of Warrant Activity
|  |  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Fair Value |  |  | Weighted Average Remaining Contractual Life (Years) |
Outstanding at December 31, 2023 |  |  |  | 16,167 |  |  | $ | 264.30 |  |  | $ | 38.70 |  |  |  | 3.0 |
Granted |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Expired |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Forfeited/Cancelled |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Exercised |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Outstanding at December 31, 2024 |  |  |  | 16,167 |  |  | $ | 264.30 |  |  | $ | 30.00 |  |  |  | 2.0 |
Granted |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Expired |  |  |  | (667 | ) |  |  | 42.00 |  |  |  | 455.70 |  |  |  |  |
Forfeited/Cancelled |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Exercised |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  |  |
Outstanding at December 31, 2025 |  |  |  | 15,500 |  |  | $ | 273.75 |  |  | $ | - |  |  |  | 1.0 |
Schedule of Recognized Stock-Based Compensation Expense | The Company recognized stock-based compensation expense as follows: Schedule of Recognized Stock-Based Compensation Expense
|  | Years Ended December 31, |
|  | 2025 |  |  | 2024 |
Cost of sales |  | $ | - |  |  | $ | 20,831 |
Sales and marketing |  |  | 355,838 |  |  |  | 1,068,175 |
General and administrative |  |  | 1,929,440 |  |  |  | 3,985,281 |
Research and development |  |  | (37,225 | ) |  |  | 360,617 |
Total stock-based compensation expense |  | $ | 2,248,053 |  |  | $ | 5,434,904 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration